References
Apr 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·D Bobon, B Woggon
Feb 1, 1983·Psychological Medicine·T P HoganR Eastwood
Jun 30, 1994·The New England Journal of Medicine·J P Kassirer
Dec 1, 2000·BMJ : British Medical Journal·E WardJ Addington-Hall
Apr 3, 2001·BMJ : British Medical Journal·C ChilversUNKNOWN Counselling versus Antidepressants in Primary Care Study Group
Oct 3, 2001·The Journal of Nervous and Mental Disease·M S SwartzV A Hiday
Feb 13, 2002·The Journal of Clinical Psychiatry·Alex HoferW Wolfgang Fleischhacker
Jul 15, 2003·Human Psychopharmacology·Hervé AllainJean-Marc Gandon
Aug 2, 2003·The International Journal of Neuropsychopharmacology·Bruce J KinonSara Kollack-Walker
Aug 30, 2003·Clinical Therapeutics·Steven M SteinbergUNKNOWN Prefer Study Group
Oct 20, 2004·The Journal of Clinical Psychiatry·Oliver FreudenreichDonald C Goff
Mar 15, 2005·Clinical Therapeutics·Paul A NausiedaJohn T Slevin
May 17, 2005·Patient Education and Counseling·Kristina H JahngM Robin DiMatteo
Jul 6, 2005·Archives of General Psychiatry·Jennifer C DayCheryl Power
Aug 9, 2005·Current Medical Research and Opinion·Andrew J Dowson, Per Almqvist
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Feb 10, 2006·Acta Psychiatrica Scandinavica·A O AdewuyaA B Eegunranti
Apr 4, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Louise Howard, Graham Thornicroft
Feb 21, 2007·Psychopharmacology·Diego NovickDieter Naber
Aug 11, 2007·International Clinical Psychopharmacology·Stephan HeresFrank-Gerald Pajonk
Sep 22, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Istvan BitterGabor S Ungvari
Oct 9, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Richard L Street
Mar 14, 2008·Human Psychopharmacology·Jamie KaragianisBharat Chawla
Apr 1, 2008·Lancet·René S KahnUNKNOWN EUFEST study group
Jun 28, 2008·Journal of Psychopharmacology·M X PatelA David
Jul 1, 2008·Schizophrenia Bulletin·Somaia MohamedJeffrey A Lieberman
Sep 20, 2008·CNS Neuroscience & Therapeutics·Luis SanInmaculada Gilaberte
Nov 4, 2008·BMJ : British Medical Journal·UNKNOWN Preference Collaborative Review Group
Nov 19, 2008·The American Journal of Psychiatry·Stefan LeuchtJohn M Davis
Jan 1, 2007·Patient Preference and Adherence·Jörg CzekallaBruce Kinon
May 1, 2008·Expert Review of Clinical Pharmacology·A RogerM Artés
Citations
Feb 22, 2012·Patient Preference and Adherence·William MontgomeryGavan Harrison
Apr 26, 2014·PloS One·Maarten BakMarjan Drukker
Oct 31, 2013·Drugs in R&D·David HobbsJoel Raskin
Oct 17, 2015·Drug Development and Industrial Pharmacy·Hemlata G PatilKamalinder K Singh
Nov 29, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ichiro KusumiTsukasa Koyama
Oct 18, 2011·Clinical Therapeutics·Dorrit Østergaard NilausenJoop van Gerven
Apr 5, 2012·Human Psychopharmacology·Susanne KraemerFréderic Rouillon
Jul 22, 2015·International Clinical Psychopharmacology·Jun Soo KwonEunJung Lee
Mar 5, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Marta Slavkova, Jörg Breitkreutz
May 11, 2017·Pharmaceutical Development and Technology·Hesham M TawfeekGhareb M Soliman
Jul 8, 2017·CNS Spectrums·Andrew J Cutler, Gregory W Mattingly
Jun 14, 2019·PloS One·P TakácsI Bitter
Aug 8, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Ziyi Lin, Jianwei Xuan
Jan 18, 2020·Pharmaceutics·Enrica MendittoIsabel F Almeida